Physician profile
Susan Alex
NPI 1003864117
$1,784.75
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $288 · 2020: $457 · 2021: $345 · 2022: $417 · 2023: $188 · 2024: $90.32.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $234 · Education: $43.89.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $234.31 |
| Education | $43.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $349.23 | 2019-2022 | |
| Glaxosmithkline, LLC. | $251.91 | 2020-2023 | Benlysta |
| Amgen INC. | $230.93 | 2019-2023 | Tavneos |
| Opko Pharmaceuticals, LLC | $181.81 | 2020-2023 | Rayaldee |
| Astrazeneca Pharmaceuticals LP | $171.29 | 2019-2023 | Farxiga |
| Vifor Pharma, INC. | $143.72 | 2019-2022 | |
| Aurinia Pharma U.S., INC. | $120.57 | 2021-2022 | |
| Ultragenyx Pharmaceutical INC. | $87.24 | 2024 | Crysvita |
| Akebia Therapeutics INC | $76.05 | 2020-2023 | Auryxia |
| Travere Therapeutics, INC. | $41.78 | 2023-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $36.80 | 2022-2023 | |
| Genzyme Corporation | $22.74 | 2022 | |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $20.24 | 2019 | |
| Daiichi Sankyo INC. | $17.92 | 2020 | |
| Mallinckrodt Hospital Products INC. | $16.52 | 2023 | Terlivaz |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Enterprises LLC | $16.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Alex listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.